Lisata Therapeutics
LSTA
58 hedge funds and large institutions have $21M invested in Lisata Therapeutics in 2014 Q2 according to their latest regulatory filings, with 27 funds opening new positions, 18 increasing their positions, 6 reducing their positions, and 7 closing their positions.
286% more first-time investments, than exits
New positions opened: 27 | Existing positions closed: 7
200% more repeat investments, than reductions
Existing positions increased: 18 | Existing positions reduced: 6
67% more capital invested
Capital invested by funds: $12.6M → $21M (+$8.41M)
53% more funds holding
Funds holding: 38 → 58 (+20)
42% less call options, than puts
Call options by funds: $793K | Put options by funds: $1.38M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$3.8M |
| 2 |
PRCM
Pine River Capital Management
Minnetonka,
Minnesota
|
+$3.44M |
| 3 |
BIT
BlackRock Institutional Trust
San Francisco,
California
|
+$1.36M |
| 4 |
State Street
Boston,
Massachusetts
|
+$1.23M |
| 5 |
TCIM
TIAA CREF Investment Management
New York
|
+$633K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
IHM
Iguana Healthcare Management
New York
|
-$1.41M |
| 2 |
U
UBS
Zurich,
Switzerland
|
-$364K |
| 3 |
DC
Deere & Company
Moline,
Illinois
|
-$325K |
| 4 |
LP
LMR Partners
London,
United Kingdom
|
-$162K |
| 5 |
Morgan Stanley
New York
|
-$150K |
LSTA Hedge Fund Activity: Q2 2014 in Review
58 of the 3,479 institutional investors tracked by Wall St. Rank reported a position in Lisata Therapeutics (LSTA) for Q2 2014, worth a combined $21M — up 67% from $12.6M a quarter earlier.
Buyers outnumbered sellers: 27 funds opened new LSTA positions and 7 closed out — a net gain of 20 holders — while 18 added to existing stakes and 6 trimmed.
The largest buyer was BlackRock Fund Advisors, opening a new position worth an estimated $3.8M. The largest seller was Iguana Healthcare Management, exiting entirely with an estimated $1.41M sold.
- 58 institutional investors held Lisata Therapeutics (LSTA) as of Q2 2014, up from 38 in Q1 2014.
- Funds reported $21M of Lisata Therapeutics stock for Q2 2014, up 67% quarter-over-quarter.
- 27 funds opened new Lisata Therapeutics positions in Q2 2014 and 7 closed out, a net change of +20 holders.
- The largest Lisata Therapeutics buyer in Q2 2014 was BlackRock Fund Advisors, an estimated $3.8M added.
- The largest Lisata Therapeutics seller in Q2 2014 was Iguana Healthcare Management, an estimated $1.41M sold.
Based on aggregated 13F filings for Q2 2014.